Watanabe H - Search Results

1

Lower CH50 as a predictor for intractable or recurrent lupus enteritis: A retrospective observational study.

Yoshida Y, Omoto T, Kohno H, Tokunaga T, Kuranobu T, Yukawa K, Watanabe H, Oi K, Sugimoto T, Mokuda S, Nojima T, Hirata S, Sugiyama E. Yoshida Y, et al. Among authors: watanabe h. Mod Rheumatol. 2021 May;31(3):643-648. doi: 10.1080/14397595.2020.1812871. Epub 2020 Sep 7. Mod Rheumatol. 2021. PMID: 32815450

2

Risk Factors for Pneumocystis jirovecii Pneumonia in Patients With Rheumatoid Arthritis and a Prophylactic Indication of Trimethoprim/Sulfamethoxazole.

Yukawa K, Nagamoto Y, Watanabe H, Funaki M, Iwahashi M, Yamana J, Sasaki R, Yamana S. Yukawa K, et al. Among authors: watanabe h. J Clin Rheumatol. 2018 Oct;24(7):355-360. doi: 10.1097/RHU.0000000000000731. J Clin Rheumatol. 2018. PMID: 29664819

3

Asymptomatic coronary aneurysms in a patient with eosinophilic granulomatosis with polyangiitis who developed a digital gangrene.

Sato M, Yoshida Y, Sugimoto T, Kishimoto S, Omoto T, Watanabe H, Tokunaga T, Yukawa K, Kohno H, Mokuda S, Nojima T, Hirata S, Sugiyama E. Sato M, et al. Among authors: watanabe h. Mod Rheumatol Case Rep. 2021 Jan;5(1):130-136. doi: 10.1080/24725625.2020.1810404. Epub 2020 Aug 25. Mod Rheumatol Case Rep. 2021. PMID: 32791887 Review.

4

Tapering and discontinuation of oral glucocorticoids without deterioration of disease status in patients with rheumatoid arthritis under a stable treatment.

Hirata S, Kohno H, Watanabe H, Tokunaga T, Yoshida Y, Sugimoto T, Mokuda S, Oda K, Nojima T, Sugiyama E. Hirata S, et al. Among authors: watanabe h. Mod Rheumatol. 2021 Jul;31(4):803-808. doi: 10.1080/14397595.2020.1864914. Epub 2021 Mar 8. Mod Rheumatol. 2021. PMID: 33325280

5

C-reactive protein and ground-glass opacity as predictors for intractable interstitial lung disease in patients with systemic sclerosis under cyclophosphamide treatment regardless of concomitant glucocorticoids.

Yoshida Y, Sugimoto T, Hosokawa Y, Suma H, Kobayashi H, Ishitoku M, Kohno H, Tokunaga T, Watanabe H, Mokuda S, Nojima T, Hirata S, Sugiyama E. Yoshida Y, et al. Among authors: watanabe h. Mod Rheumatol. 2022 Jan 5;32(1):141-148. doi: 10.1080/14397595.2021.1907014. Mod Rheumatol. 2022. PMID: 33775207

6

The clinical characteristics and predictors of severe digital ischemia in patients with anti-aminoacyl transfer RNA synthetase antibodies.

Suma H, Yoshida Y, Sugimoto T, Matsuo Y, Law SM, Nakashima R, Kobayashi H, Hosokawa Y, Ishitoku M, Kohno H, Watanabe H, Tokunaga T, Mokuda S, Nojima T, Hirata S, Sugiyama E. Suma H, et al. Among authors: watanabe h. J Dermatol. 2021 Jul;48(7):1044-1051. doi: 10.1111/1346-8138.15884. Epub 2021 Apr 13. J Dermatol. 2021. PMID: 33847003 Review.

7

Nailfold capillaries and myositis-specific antibodies in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis.

Sugimoto T, Mokuda S, Kohno H, Ishitoku M, Araki K, Watanabe H, Tokunaga T, Yoshida Y, Hirata S, Sugiyama E. Sugimoto T, et al. Among authors: watanabe h. Rheumatology (Oxford). 2022 May 5;61(5):2006-2015. doi: 10.1093/rheumatology/keab681. Rheumatology (Oxford). 2022. PMID: 34498053

8

Comment on: Nailfold capillaries and myositis-specific antibodies in anti-melanoma differentiation-associated gene 5 antibody-positive DM. Reply.

Sugimoto T, Mokuda S, Kohno H, Ishitoku M, Araki K, Watanabe H, Tokunaga T, Yoshida Y, Hirata S, Sugiyama E. Sugimoto T, et al. Among authors: watanabe h. Rheumatology (Oxford). 2022 May 5;61(5):e122-e124. doi: 10.1093/rheumatology/keab822. Rheumatology (Oxford). 2022. PMID: 34726739 No abstract available.

9

The Lipopolysaccharide Mutant Re-LPS Is a Useful Tool for Detecting LPS Contamination in Rheumatoid Synovial Cell Cultures.

Kohno H, Ouhara K, Mokuda S, Tokunaga T, Sugimoto T, Watanabe H, Ishitoku M, Yoshida Y, Mizuno N, Ozawa T, Kawataka M, Hirata S, Kishi H, Sugiyama E. Kohno H, et al. Among authors: watanabe h. Pathobiology. 2022;89(2):92-100. doi: 10.1159/000520022. Epub 2021 Nov 19. Pathobiology. 2022. PMID: 34802006

10

N¹-methylpseudouridine-incorporated mRNA enhances exogenous protein expression and suppresses immunogenicity in primary human fibroblast-like synoviocytes.

Mokuda S, Watanabe H, Kohno H, Ishitoku M, Araki K, Hirata S, Sugiyama E. Mokuda S, et al. Among authors: watanabe h. Cytotechnology. 2022 Aug;74(4):503-514. doi: 10.1007/s10616-022-00540-4. Epub 2022 Jun 30. Cytotechnology. 2022. PMID: 35791402 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,029 results

Search Page